Medicines Evaluation Board
Impact in
- Toxicology top 5%
- Pharmacovigilance and Adverse Drug Reactions
Papers in
- Toxicology 72
- Pharmacovigilance and Adverse Drug Reactions 70
-
- Pharmaceutical studies and practices 101
- Top scholars
- Sabine M. J. M. StrausBruno H. StrickerHubert G. M. LeufkensMarcel KwaMiriam SturkenboomCarla HerbertsAukje K. Mantel‐TeeuwisseRaymond Ostelo
- Journals
- Drug Safety (68 papers)British Journal of Clinical Pharmacology (41 papers)Clinical Pharmacology & Therapeutics (37 papers)Drug Discovery Today (30 papers)Regulatory Toxicology and Pharmacology (20 papers)
- Partner nations
- NetherlandsUnited StatesGermany
In The Last Decade
Medicines Evaluation Board
658 papers receiving 16.8k citations
Peers
Comparison fields: 5 of 224
- Toxicology 1.3k
- Geriatrics and Gerontology 377
- Family Practice 192
- Pharmacology 1.8k
- Pediatrics, Perinatology and Child Health 1.6k
Countries citing scholars working at Medicines Evaluation Board
This map shows the geographic impact of research produced by authors working at Medicines Evaluation Board. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Medicines Evaluation Board with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Medicines Evaluation Board more than expected).
Fields of papers published by authors at Medicines Evaluation Board
This network shows the impact of papers affiliated with Medicines Evaluation Board at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Medicines Evaluation Board at the time of their publication.
About Medicines Evaluation Board
In recent decades, authors affiliated with Medicines Evaluation Board have published 834 papers, which have received a total of 21.8k indexed citations . Scholars at this organization have produced 72 papers in Toxicology, 115 papers in Pediatrics, Perinatology and Child Health, 47 papers in Statistics and Probability, 17 papers in Geriatrics and Gerontology and 144 papers in Economics and Econometrics on the topics of Health Systems, Economic Evaluations, Quality of Life (106 papers), Pharmaceutical studies and practices (101 papers), Pharmaceutical Economics and Policy (78 papers), Pharmacovigilance and Adverse Drug Reactions (70 papers), Biosimilars and Bioanalytical Methods (50 papers), Statistical Methods in Clinical Trials (46 papers), Biomedical Ethics and Regulation (38 papers) and Carcinogens and Genotoxicity Assessment (27 papers). Their work is cited by papers focused on Toxicology (1.3k citations), Geriatrics and Gerontology (377 citations), Family Practice (192 citations), Pharmacology (1.8k citations) and Pediatrics, Perinatology and Child Health (1.6k citations). Authors at Medicines Evaluation Board collaborate with scholars in Netherlands, United States and Germany and have published in prestigious journals including Drug Safety, British Journal of Clinical Pharmacology, Clinical Pharmacology & Therapeutics, Drug Discovery Today and Regulatory Toxicology and Pharmacology. Some of Medicines Evaluation Board's most productive authors include Sabine M. J. M. Straus, Bruno H. Stricker, Hubert G. M. Leufkens, Marcel Kwa, Miriam Sturkenboom, Carla Herberts, Aukje K. Mantel‐Teeuwisse, Raymond Ostelo, Henrica C. W. de Vet and L.M. Bouter.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.